Focused Wealth Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-31
Closed -$2K 682
2018
Q3
$2K Buy
+31
New +$2K ﹤0.01% 579
2016
Q1
Sell
-80
Closed -$3K 652
2015
Q4
$3K Hold
80
﹤0.01% 544
2015
Q3
$2K Hold
80
﹤0.01% 579
2015
Q2
$3K Sell
80
-320
-80% -$14.4K ﹤0.01% 548
2015
Q1
$20K Hold
400
0.01% 313
2014
Q4
$18K Buy
+400
New +$15.7K 0.01% 322

Other funds holding AVNS

Focused Wealth Management's AVNS Position: Q4 2018 in Review

Focused Wealth Management sold out of Avanos Medical (AVNS) in Q4 2018, closing a stake of 31 shares — an estimated $2K sold.

Focused Wealth Management first reported a position in AVNS in Q4 2014 and held it in 6 quarters. The position peaked at $20K in Q1 2015. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2018.

  • Focused Wealth Management reported no remaining Avanos Medical position as of Q4 2018 after selling out during the quarter.
  • Focused Wealth Management sold 31 Avanos Medical shares in Q4 2018, an estimated $2K.
  • Focused Wealth Management first reported a position in Avanos Medical in Q4 2014 and held it in 6 quarters.
  • Focused Wealth Management's Avanos Medical position peaked at $20K in Q1 2015.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2018.

Based on Focused Wealth Management's 13F filing for Q4 2018, filed 30 Jan 2019.